Objective. Breast cancer simulation models must take changing mortality rates into account to evaluate the potential impact of cancer control interventions. We estimated mortality rates due to breast cancer and all other causes combined to determine their impact on overall mortality by year, age, and birth cohort. Methods. Based on mortality rates from publicly available datasets, an age-period-cohort model was used to estimate the proportion of deaths due to breast cancer for US women aged 0 to 119 years, with birth years 1900 to 2000. Breast cancer mortality was calculated as all-cause mortality multiplied by the proportion of deaths due to breast cancer; other-cause mortality was the difference between all-cause and breast cancer mortality. Results. Breast cancer and other-cause mortality rates were higher for older ages and birth cohorts. The percent of deaths due to breast cancer increased across birth cohorts from 1900 to 1940 then decreased. Among 50-year-old women, in the 1920 birth cohort, 52 (9.9%) of 100,000 deaths (95% CI, 9.8% to 10.1%) were attributed to breast cancer whereas 476 of 100,000 were due to other causes; in the 1960 birth cohort, 22 (8.5%) of 100,000 deaths (95% CI, 8.3% to 8.7%) were attributed to breast cancer with 242 of 100,000 deaths due to other causes. The percentage of all deaths due to breast cancer was highest (4.1% to 12.9%) for women in their 40s and 50s for all birth cohorts. Conclusions. This study offers evidence that advances in breast cancer screening and treatment have reduced breast cancer mortality for women across the age spectrum, and provides estimates of age-, year-and birth cohort-specific competing mortality rates for simulation models. Other-cause mortality estimates are important in these models because most women die from causes other than breast cancer. Breast cancer is a leading cause of death among women in the United States, with over 40,000 women dying from breast cancer annually.
Breast cancer is a leading cause of death among women in the United States, with over 40,000 women dying from breast cancer annually.
1,2 Breast cancer mortality rates have steadily declined over the past 25 years. 3 Between 1990 and 2015, breast cancer mortality decreased approximately 39%. 2, 4 However, these declines have not been equal across all age groups, with the youngest and oldest women having a smaller decline in breast cancer mortality than other women. 5, 6 Previous studies have also identified differences in breast cancer mortality patterns by birth cohort, with those born between 1900 and 1950 having a higher proportion of deaths from breast cancer than women born after 1950.
Population-based simulation modeling of breast cancer within the Cancer Intervention and Simulation Modeling Network (CISNET) has been used to quantify the relative contributions of screening and treatment to these observed patterns of declines in breast cancer mortality rates. The models have also been used to forecast the benefits, harms, and costs of alternative screening and treatment interventions on breast cancer death rates. [9] [10] [11] [12] [13] Such simulations require accurate estimates of trends in non-breast cancer (''other cause'') mortality over age, time periods and birth cohorts to account for competing risks of death. 7, 8 Since both all-cause and breast cancer-specific mortality rates have been changing over time, estimates of other-cause mortality rates (which are the simple difference of the 2) require regular updates. Therefore, the overarching goal of this paper was to apply statistical methods to the latest available data to derive breast cancer and other-cause mortality by age and birth cohort. These data are intended for use in simulation modeling. In addition, these data can be used to illustrate the relative and absolute impact of breast cancer mortality on overall mortality for different birth cohorts.
Methods
The objective of this analysis was to estimate the rates of death due to breast cancer (breast cancer mortality) and deaths due to causes other than breast cancer (othercause mortality) according to birth year and age. This study was done as part of the CISNET Breast Working Group using observed mortality trends through 2014; prior analyses were based on data available through 1999. 7 Only publicly available anonymous data were used; therefore, this study was determined to be exempt from human subjects review by the University of Wisconsin Health Sciences Institutional Review Board.
Data Sources
Breast cancer (ICD-10 C50) and all-cause female deaths by single year of age (0 to 99 years) for the calendar year of death period from 1999 to 2014 were obtained from the Detailed Mortality file on CDC WONDER. 1 14 
Analysis
We used an age-period-cohort (APC) model 15 to estimate the proportion of deaths due to breast cancer for all ages (0 to 119 years) and birth years (1900 to 2000) of interest from the Detailed and Compressed Mortality Data with an over-dispersed (quasibinomial) generalized additive logistic regression model. 16 The APC modeling approach was chosen, as it provided estimates for the proportion of deaths due to breast cancer for all single years of age, years of birth, and calendar years; 95% CI around the proportions were calculated using the standard approach (61.96 3 SE) on the logit scale. Age, period (calendar year of death) and cohort (calendar year of birth) were entered into the logistic regression model as additive thin-plate regression splines. 17 The APC model cannot be uniquely parameterized due to the linear dependence of age, period, and cohort (age = period 2 cohort), which prevents the estimation of linear trends for all 3 factors (age, period and cohort). Following the identification strategy of Carstensen, 15 linear terms were included in the age and cohort effects, whereas the period effect was constrained to have 0 slope on average. The thin-plate splines were constrained to be linear for age .99 years and periods before 1968 and after 2014. The smoothing parameters for the thin plate regression splines were selected to optimize the goodness-of-fit of the regression by generalized cross-validation, which penalized possible overfitting. 18 Data for single years of age were only available for calendar years 1999 to 2014; for earlier years, age groups were converted to the corresponding central age of the 5-year group for analysis (0, 2.5, 7, 12, 17, 22, 29.5, 39.5, 49.5, 59.5, 69.5, 79.5 and 92).
Breast cancer mortality was calculated as all-cause mortality from the Berkeley Mortality Database multiplied by the proportion of deaths due to breast cancer. Other-cause mortality was the difference between allcause mortality and breast cancer mortality.
Estimates are provided for birth years 1900 through 1990, since 1990 is the last decade with observed breast cancer deaths by 2014; extrapolations through birth year 2000 are available in an online interactive resource (https://resources.cisnet.cancer.gov/projects/#bcr/bcmort). Analysis was conducted using the mgcv 16, 17 and ggplot2 19 packages in R v3.3.1.
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Results
As a fraction of all deaths, breast cancer mortality increased from the 1900 to the 1940 birth cohort, and was estimated to have since declined through 1990 to a level lower than observed in 1900 ( Figure 1) ; the percent of deviance explained by the model is 99.7%. The percent of all deaths attributable to breast cancer in 50-year-old women increased from 7.3% (95% CI, 6.1% to 8.8%) in the 1900 birth cohort to peak at 12.9% (95% CI, 12.7% to 13.1%) for the 1940 birth cohort. We estimate that 4.1% (95% CI, 2.8% to 6.1%) of deaths in the 1990 birth cohort among 50-year-old women will be due to breast cancer. As expected, other-cause mortality rates generally increased with age ( Figure 2A ). For example, in the 1940 birth cohort, other-cause mortality increased from 97 per 100,000 30-year-old women to 1,874 per 100,000 70-year-old women (Table 1) . Other-cause mortality rates have steadily fallen across birth cohorts across all years (1900 to 1990). For example, we estimate that among 50-year-olds, other-cause mortality decreased from 608 per 100,000 women born in 1900 to 309 per 100,000 women born in 1940 (a 49% decrease) to 209 per 100,000 women born in 1990 (an additional 32% decrease).
Breast cancer mortality rates also generally increased with age ( Figure 2B) ; breast cancer mortality rates increased from 4 per 100,000 for 30-year-olds to 90 per 100,000 70-year-old women born in 1940 (Table 1) . Breast cancer mortality rates have decreased for most but not all birth cohorts since 1900, with rates among 50-year-old women in early birth cohorts virtually unchanged (48 deaths per 100,000 women in the 1900 birth cohort and 46 deaths per 100,000 women in 1940) before declining to 22 deaths per 100,000 women in the 1960 birth cohort and an estimated 9 deaths per 100,000 women in the 1990 birth cohort (Table 1) .
Discussion
Our results show that mortality, breast cancer mortality, and other-cause mortality rates have decreased for women of all ages in recent birth cohorts. Overall, ageadjusted breast cancer mortality rates have been decreasing since 1990; 3 between 1990 and 2015, breast cancer mortality rates dropped by 39%. 4 Early detection efforts with mammography screening and improvements in breast cancer therapy have both contributed to declines in breast cancer mortality rates. 21 Breast cancer deaths in the most recent birth cohort (1990) contribute less to overall mortality than in the 1940 birth cohort-when breast cancer had its greatest impact; breast cancer also contributes less to overall mortality in the most recent birth cohort than in the 1900 birth cohort, the first cohort for which we estimated death rates.
The reduction in mortality seen for breast cancer over time has also been observed for other cancers in women affected by improvements in early detection and treatment; for example, colorectal cancer mortality rates declined by 44% in women between 1990 and 2015. 4 Our study extends previous work by Rosenberg (Appendix Table) , 7 who used similar life table methods applied to earlier versions of the Berkeley Mortality Database and breast cancer mortality data provided by the National Center for Health Statistics to obtain othercause mortality rates. We estimate that, among 50-yearold women born in 1940, 12.9% (95% CI, 12.7% to 13.1%) of deaths were attributable to breast cancer, whereas Rosenberg 7 estimated that 13.4% of deaths were attributable to breast cancer, resulting in estimated other-cause mortality of 309 per 100,000 women from our model versus 307 per 100,000 women from Rosenberg. Rosenberg's model estimated that breast cancer's relative contribution to overall mortality peaked at 15% in 43-year-olds born in 1947, whereas we estimated a similar peak of 14% in 46-year-olds born in 1945. 7 Larger differences are evident for younger women in earlier periods. For example, for 30-year-olds, we estimate 11 breast cancer deaths per 100,000 women for the 1900 birth cohort, 9 per 100,000 women for the 1910 birth cohort and 5 per 100,000 women for the 1920 birth cohort, whereas Rosenberg estimates 4 breast cancer deaths per 100,000 women for all 3 cohorts, essentially using the estimated breast cancer mortality for the 1920 cohort for all prior cohorts. Similarly, we assumed that period effects in future years followed a linear trend, so that our estimates for breast cancer mortality after the year 1999 are larger than estimates provided by Rosenberg. To the extent that period effects on the percentage of deaths attributable to breast cancer after the year 2014 deviates from a linear pattern on the logit scale, our estimates will be in error.
Vilaprinyo and others 8 calculated other-cause mortality for Catalonia, Spain, using a life table approach. Their results were similar to our findings, showing that the impact of breast cancer on all-cause mortality was greatest for women born around 1950 in the 40 to 49 years age group, and that the proportion of deaths due to breast cancer has declined in recent birth cohorts. Other investigators have used time series analysis to forecast future breast cancer rates for the United States; 5 because source data are essentially identical for all researchers (i.e., arising from national death statistics), study findings are concordant. Another study used survival analysis to 
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calculate other-cause mortality restricted to adult (ages 50 years) cancer patients to provide insight into noncancer-related health issues among cancer patients and their risk of dying from other causes. 22 Their cumulative survival probability estimates are specifically designed for research investigating the impact of various treatment approaches in adults diagnosed with cancer (among whom the risk of death from cancer is relatively high), and are not directly comparable to our mortality rates based on women at risk of breast cancer (among whom the risk of death from cancer is relatively low).
Our study contrasts with the approach of Wang and others, 23 who used Poisson regression and mortality data linked to the National Health and Nutrition Examination Survey (NHANES) to adjust standard life tables for relative risks of mortality due to age, race, smoking status and body mass index during 1970 to 2003. The estimates by Wang and others 23 were limited by their use of NHANES risk factor data, which is collected at one time point, to predict long-term mortality. However, these estimates provide an approach for considering mortality according to demographic and lifestyle factors that influence both overall and breast cancer mortality differentially by age. Future research is needed to further refine the contribution of breast cancer to overall mortality for subgroups defined by age, 5, 6, 8 race, 2,5,24 as well as molecular subtypes of breast cancer, 6 ,11 because these factors have important disparate impacts on the risk of death before and after a breast cancer diagnosis.
While the results for mortality trends are consistent with earlier research, there are some caveats that should be considered in evaluating our approach. As mentioned above, we made assumptions regarding extrapolations for age .99 years and periods before 1968 and after 2014 to generate plausible estimates of other-cause mortality for simulation modeling. Estimates depended on the availability of accurate and complete mortality data. While historical national death data are available, annual all-cause mortality data were not available for single years of age, so that interpolations were necessary within 5-year age groups. CISNET simulation modelers may also make assumptions in applying these other-cause mortality estimates in their breast cancer investigations. For example, the simulation models may assume that survivors of breast cancer have the same other-cause mortality risk as women without breast cancer, or that women who obtain mammograms have similar othercause mortality as women without a history of screening (e.g., ignoring a ''healthy screener'' effect). Recent analyses show that women with early-stage breast cancer may have lower other-cause mortality compared with the general population, 22 and that women who receive mammograms are also more likely to fill medication prescriptions and engage in physical activity and are less likely to smoke cigarettes. 25, 26 Overall, we found that the relative contribution of breast cancer to mortality from all causes has been decreasing for women of all ages in recent birth cohorts. These results provide evidence that the nation's substantial investments in breast cancer screening and treatment have reduced breast cancer mortality for women across the age spectrum. 27 Since most women diagnosed with breast cancer die from causes other than breast cancer, our results should be useful as inputs for computer microsimulation and other studies seeking to identify optimal breast cancer prevention, detection, and treatment strategies to improve population health.
